KNSA

KNSA

USD

Kiniksa Pharmaceuticals International plc Class A Ordinary Shares

$38.755-0.325 (-0.832%)

リアルタイム価格

Healthcare
Drug Manufacturers - Specialty & Generic
英国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$39.080

高値

$39.220

安値

$38.570

出来高

0.35M

企業ファンダメンタルズ

時価総額

2.9B

業種

Drug Manufacturers - Specialty & Generic

United Kingdom

取引統計

平均出来高

0.46M

取引所

NMS

通貨

USD

52週レンジ

安値 $17.82現在値 $38.755高値 $42.05

関連ニュース

Analyst Upgrades

Goldman Sachs Maintains Buy on Kiniksa Pharmaceuticals, Raises Price Target to $55

Goldman Sachs analyst Paul Choi maintains Kiniksa Pharmaceuticals with a Buy and raises the price target from $45 to $55.

もっと見る
Goldman Sachs Maintains Buy on Kiniksa Pharmaceuticals, Raises Price Target to $55
GlobeNewswire

Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution

– ARCALYST® (rilonacept) Q3 2025 net product revenue of $180.9 million, representing 61% year-over-year growth –– ARCALYST 2025 expected net product revenue raised to $670 - $675 million –– KPL-387 granted Orphan

もっと見る
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
Analyst Upgrades

Wedbush Maintains Outperform on Kiniksa Pharmaceuticals, Raises Price Target to $44

Wedbush analyst David Nierengarten maintains Kiniksa Pharmaceuticals with a Outperform and raises the price target from $38 to $44.

もっと見る
Wedbush Maintains Outperform on Kiniksa Pharmaceuticals, Raises Price Target to $44

最新情報を入手

価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。